Risks and benefits of clozapine and lithium co-prescribing: a systematic review and expert recommendations
Objectives To identify the risks and benefits of clozapine‑lithium co-prescription. Methods
Articles published in English or French were identified with a MEDLINE, Web of Sciences …
Articles published in English or French were identified with a MEDLINE, Web of Sciences …
Nonchemotherapy drug-induced neutropenia and agranulocytosis: could medications be the culprit?
AM Pick, KK Nystrom - Journal of pharmacy practice, 2014 - journals.sagepub.com
Drug-induced agranulocytosis is a severe complication that has been implicated with most
classes of medications. Medications such as clozapine, trimethoprim-sulfamethoxazole and …
classes of medications. Medications such as clozapine, trimethoprim-sulfamethoxazole and …
[HTML][HTML] Japanese society of neuropsychopharmacology:“Guideline for pharmacological therapy of schizophrenia”
JS of Neuropsychopharmacology - Neuropsychopharmacology …, 2021 - ncbi.nlm.nih.gov
Guidelines for schizophrenia treatment have been created in various countries and have
been translated and used in Japan as well. However, the available drugs and their …
been translated and used in Japan as well. However, the available drugs and their …
[HTML][HTML] Psychotic disorders in children and adolescents: a primer on contemporary evaluation and management
JR Stevens, JB Prince, LM Prager… - The primary care …, 2014 - psychiatrist.com
The Psychiatric Consultation Service at Massachusetts General Hospital (MGH) sees
medical and surgical inpatients with comorbid psychiatric symptoms and conditions. During …
medical and surgical inpatients with comorbid psychiatric symptoms and conditions. During …
Off-label use of clozapine in children and adolescents—A literature review
V Rachamallu, BW Elberson, E Vutam… - American Journal of …, 2019 - journals.lww.com
Background: Clozapine is a second-generation antipsychotic typically used for refractory
schizophrenia or otherwise psychotic pathology. There are no FDA or manufacturer …
schizophrenia or otherwise psychotic pathology. There are no FDA or manufacturer …
Haematological toxicity of clozapine and some other drugs used in psychiatry
PMM Nooijen, F Carvalho… - … Clinical and Experimental, 2011 - Wiley Online Library
Objective To review recent work on the haematological toxicity of clozapine and some other
drugs used in psychiatry concerning especially (i) the mechanism of antipsychotic‐induced …
drugs used in psychiatry concerning especially (i) the mechanism of antipsychotic‐induced …
Clozapine safety, 40 years later
M Raja, S Raja - Current drug safety, 2014 - ingentaconnect.com
Clozapine is, and will remain in the coming years, an irreplaceable drug in psychiatry which
has elective indication in treatment-resistant schizophrenia, suicide risk in schizophrenia …
has elective indication in treatment-resistant schizophrenia, suicide risk in schizophrenia …
Clozapine safety, 35 years later
M Raja - Current drug safety, 2011 - ingentaconnect.com
Clozapine is the best treatment option in several clinical circumstances, including treatment-
resistant schizophrenia, non treatment-resistant schizophrenia, suicide risk in schizophrenia …
resistant schizophrenia, non treatment-resistant schizophrenia, suicide risk in schizophrenia …
Putative mechanisms of action and clinical use of lithium in children and adolescents: a critical review
S Pisano, M Pozzi, G Catone, G Scrinzi… - Current …, 2019 - ingentaconnect.com
Background: Lithium is a first-line treatment for bipolar disorder in adults, but its mechanism
of action is still far from clear. Furthermore, evidences of its use in pediatric populations are …
of action is still far from clear. Furthermore, evidences of its use in pediatric populations are …
Clozapine re-challenge and initiation following neutropenia: a review and case series of 14 patients in a high-secure forensic hospital
E Silva, M Higgins, B Hammer… - Therapeutic Advances …, 2021 - journals.sagepub.com
Objective: Clozapine remains the most effective intervention for treatment resistant
schizophrenia; however, its use is prohibited following neutropenias. We review neutrophil …
schizophrenia; however, its use is prohibited following neutropenias. We review neutrophil …